You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifaximin

Showing 26 - 50 of 237
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

Recruiting
  • IgA Monoclonal Gammopathy
  • +8 more
  • Rifaximin
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 18, 2021

Clostridium Difficile Infection Trial in Nottingham (Rifaximin, Placebo)

Completed
  • Clostridium Difficile Infection
  • Rifaximin
  • Placebo
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham Clinical Trials Unit (NCTU), Queen's Medical Centre
Oct 5, 2021

Cirrhosis, Liver, Minimal Hepatic Encephalopathy, Small Intestinal Bacterial Overgrowth Trial in Cleveland (Rifaximin)

Recruiting
  • Cirrhosis, Liver
  • +3 more
  • Rifaximin
  • Cleveland, Ohio
    Metrohealth Medical Center
Nov 23, 2021

Irritable Bowel Syndrome Trial in Shanghai (Rifaximin, Fecal microbiota transplantation)

Recruiting
  • Irritable Bowel Syndrome
  • Rifaximin
  • Fecal microbiota transplantation
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Dec 29, 2021

Cirrhosis, Ascites, Peritonitis Trial in France (Rifaximin, Placebo)

Active, not recruiting
  • Cirrhosis
  • +2 more
  • Rifaximin
  • Placebo
  • Amiens, France
  • +17 more
Jul 12, 2022

Crohn Disease Trial in Rozzano (Rifaximin delayed release tablets, Placebo)

Terminated
  • Crohn Disease
  • Rifaximin delayed release tablets
  • Placebo
  • Rozzano, Italy
    Humanitas Clinical Research Center
Sep 24, 2021

Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)

Active, not recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 3, 2021

Hepatic Encephalopathy, Cirrhosis, Liver, Portal Hypertension Trial in Belgium, Netherlands (Rifaximin 550 milligram Oral Tablet

Recruiting
  • Hepatic Encephalopathy
  • +4 more
  • Rifaximin 550 milligram Oral Tablet [XIFAXAN]
  • +2 more
  • Leuven, Belgium
  • +5 more
Feb 15, 2022

Covert Hepatic Encephalopathy Trial in Shanghai (Rifaximin)

Completed
  • Covert Hepatic Encephalopathy
  • Rifaximin
  • Shanghai, Shanghai, China
    Shanghai changzheng Hospital
Jun 28, 2021

Parkinson Disease Trial in San Francisco (Rifaximin, Placebo)

Recruiting
  • Parkinson Disease
  • Rifaximin
  • Placebo
  • San Francisco, California
    University of California San Francisco
Oct 25, 2022

Healthy Volunteers Trial in Grafton (Rifaximin Novel Formulation, Placebo)

Completed
  • Healthy Volunteers
  • Rifaximin Novel Formulation
  • Placebo
  • Grafton, Auckland, New Zealand
    Auckland Clinical Studies
Jun 16, 2021

Chronic Intestinal Pseudo-obstruction Trial in Yokohama (Rifaximin oral tablet, Placebo oral tablet)

Active, not recruiting
  • Chronic Intestinal Pseudo-obstruction
  • Rifaximin oral tablet
  • Placebo oral tablet
  • Yokohama, Kanagawa, Japan
    Yokohama city university
Jun 18, 2021

Microscopic Colitis Trial in Evanston (Rifaximin 550mg)

Recruiting
  • Microscopic Colitis
  • Rifaximin 550mg
  • Evanston, Illinois
    NorthShore University HealthSystem
Apr 14, 2021

Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Kuala Lumpur (Rifaximin, Low FODMAP diet)

Recruiting
  • Irritable Bowel Syndrome
  • Small Intestinal Bacterial Overgrowth
  • Rifaximin
  • Low FODMAP diet
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
May 4, 2021

Hepatic Encephalopathy Trial (Rifaximin)

Completed
  • Hepatic Encephalopathy
  • Rifaximin
  • (no location specified)
Feb 1, 2021

Irritable Bowel Syndrome Trial in Ann Arbor (Rifaximin 550 MG, Low FODMAP Diet)

Recruiting
  • Irritable Bowel Syndrome
  • Rifaximin 550 MG
  • Low FODMAP Diet
  • Ann Arbor, Michigan
    University of Michigan
Dec 2, 2021

Liver Cirrhosis, Chronic Hepatitis C Trial in Philadelphia (Rifaximin, Placebo)

Terminated
  • Liver Cirrhosis
  • Chronic Hepatitis C
  • Rifaximin
  • Placebo
  • Philadelphia, Pennsylvania
    Philadelphia VA Medical Center
Mar 8, 2021

Spontaneous Bacterial Peritonitis Trial in Foggia (Rifaximin, Norfloxacin)

Active, not recruiting
  • Spontaneous Bacterial Peritonitis
  • Foggia, Italy
    Ospedali Riuniti Foggia
Feb 15, 2021

Small Intestinal Bacterial Overgrowth Trial in Woolloongabba, Lucknow (device, diagnostic test, procedure, drug)

Recruiting
  • Small Intestinal Bacterial Overgrowth
  • Atmo Gas Capsule
  • +5 more
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 19, 2022

Dysbiosis Trial in Singapore (Colonic lavage with polyethylene glycol, Probiotic, Antibiotic)

Recruiting
  • Dysbiosis
  • Colonic lavage with polyethylene glycol
  • +2 more
  • Singapore, Singapore
    Changi General Hospital
Mar 7, 2022

Human Gastrointestinal Physiology Data Trial in Ann Arbor (Glucotrol XL 5Mg Extended-Release Tablet, Glipizide ER 5 MG 24 HR

Recruiting
  • Human Gastrointestinal Physiology Data
  • Glucotrol XL 5Mg Extended-Release Tablet
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Mar 19, 2022

Weight Loss Trial in Dover (Rifaximin)

Not yet recruiting
  • Weight Loss
  • Rifaximin
  • Dover, Delaware
    Bayhealth Medical Center- Dover Family Physicians and GI Consult
Dec 13, 2020

Hepatic Encephalopathy Trial in Richmond (Rifaximin, )

Completed
Has Results
  • Hepatic Encephalopathy
  • Rifaximin
  • placebo
  • Richmond, Virginia
    Hunter Holmes McGuire VA Medical Center
Dec 15, 2020

Rectal Cancer Trial in Basking Ridge, Commack, New York (Rifaximin, Placebo)

Active, not recruiting
  • Rectal Cancer
  • Rifaximin
  • Placebo
  • Basking Ridge, New Jersey
  • +2 more
Sep 21, 2021

Crohn's Disease Trial in Seattle (Fecal Microbial transplant, Normal Saline, rifaximin+omeprazole+miralax)

Terminated
  • Crohn's Disease
  • Fecal Microbial transplant
  • +2 more
  • Seattle, Washington
    Seattle Children's Hospital
Sep 23, 2021